MaxCyte (MXCT) Stock Chart & Stock Price History GBX 1.43 -0.61 (-29.90%) As of 08/7/2025 Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesInsider TradesBuy This Stock MaxCyte Stock Price Performance The MaxCyte (MXCT) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 99.57%, with a year-to-date return of -99.55%. In the past month, the stock has decreased 36.44%, reflecting recent market activity. As of the latest close, MaxCyte traded at GBX 2.06 with a market cap of £2.72 million and volume of 341,164 shares. Five years ago, the stock traded at GBX 324, representing a 99.56% decrease over that period. At the time, it had a market cap of £250.00 million and a volume of 59,967 shares. Receive MXCT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for MaxCyte and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-31.25%1 Month Performance-36.44%3 Month Performance-99.21%Year-To-Date Performance-99.55%1 Year Performance-99.57%5 Year Performance-99.56% MXCT Stock Chart for Monday, August, 11, 2025 MXCT Chart by TradingView MaxCyte Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/08/2025GBX 2.06GBX 2.06GBX 2.19GBX 2.04341,164 shs£2.72 million08/07/2025GBX 2.08GBX 2.06-0.96%GBX 2.19GBX 2.04341,164 shs£2.72 million08/06/2025GBX 2.04GBX 2.08+1.96%GBX 2.10GBX 2.02491,040 shs£2.75 million08/05/2025GBX 2.06GBX 2.04-0.97%GBX 2.06GBX 1.97597,721 shs£2.69 million08/04/2025GBX 2.06GBX 2.06GBX 2.10GBX 2.02401,667 shs£2.72 million08/01/2025GBX 2.25GBX 2.25GBX 2.27GBX 2.18334,986 shs£2.97 million07/31/2025GBX 2.25GBX 2.25GBX 2.27GBX 2.18334,986 shs£2.97 million07/30/2025GBX 2.25GBX 2.25GBX 2.27GBX 2.18334,986 shs£2.97 million07/29/2025GBX 2.27GBX 2.25-0.88%GBX 2.27GBX 2.18334,986 shs£2.97 million07/28/2025GBX 2.27GBX 2.27GBX 2.33GBX 2.24280,605 shs£3.00 million Get the Latest News and Ratings for MXCT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for MaxCyte and its competitors with MarketBeat's FREE daily newsletter. 07/25/2025GBX 2.24GBX 2.33+4.02%GBX 2.37GBX 2.26733,369 shs£3.08 million07/24/2025GBX 2.10GBX 2.24+6.67%GBX 2.30GBX 2.12530,742 shs£2.96 million07/23/2025GBX 2.02GBX 2.10+3.96%GBX 2.14GBX 2.02536,859 shs£2.77 million07/22/2025GBX 2.15GBX 2.02-6.05%GBX 2.19GBX 2.02387,729 shs£2.67 million07/21/2025GBX 2.15GBX 2.15GBX 2.19GBX 2.11437,071 shs£2.84 million07/18/2025GBX 2.11GBX 2.11GBX 2.28GBX 2.10559,271 shs£2.79 million07/17/2025GBX 2.22GBX 2.11-4.95%GBX 2.28GBX 2.10559,271 shs£2.79 million07/16/2025GBX 2.22GBX 2.22GBX 2.28GBX 2.20350,101 shs£2.93 million07/15/2025GBX 2.28GBX 2.22-2.63%GBX 2.28GBX 2.20350,101 shs£2.93 million07/14/2025GBX 2.28GBX 2.28GBX 2.31GBX 2.21665,121 shs£3.01 million07/11/2025GBX 2.22GBX 2.25+1.35%GBX 2.29GBX 2.20369,946 shs£2.97 million07/10/2025GBX 2.17GBX 2.22+2.30%GBX 2.25GBX 2.17648,379 shs£2.93 million Related Companies Neo Energy Metals Stock Chart Relx Stock Chart 3i Group Stock Chart Rentokil Initial Stock Chart WPP Stock Chart Herald Stock Chart 4imprint Group Stock Chart Resolute Mining Stock Chart PayPoint Stock Chart Ocean Wilsons Stock Chart Receive MXCT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for MaxCyte and its competitors with MarketBeat's FREE daily newsletter. This page (LON:MXCT) was last updated on 8/11/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MaxCyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MaxCyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access Sale